Navigen
Drug Stores & Pharmacies · Utah, United States · <25 Employees
View Company Info for Free
About
Headquarters
675 S Arapeen Dr Ste 103, Salt Lake City, Utah,...Phone Number
(801) 587-1417Website
www.navigenpharma.comRevenue
$7 MillionIndustry
Recent News & Media
Highlights
<$5M
Total Funding Amount
<$5M
Most Recent Funding Amount
2
Number of Funding Rounds
Who is Navigen
Navigen has built a world-class D-peptide discovery platform. It is leveraging the unique characteristics of D-peptides to develop what it believes will be novel and potentially best-in-class therapies. In addition to CPT31, Navigen has a pipeline of discovery programs targeting inflammatory conditions and cancer.Read more
Navigen Org Chart
Is Navigen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Navigen is spiking on competitors!
Click to see if Navigen had a recent Job posting/layoffs
Product Launch: Get notified when Navigen launches new products
Check if Navigen has recently received funding, and reach out quickly before it becomes old news!
Navigen, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Navigen
Earning: See what the market has to say on Navigen recently announced quarterly report
Funding: Get notified immidiatlly once Navigen has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Navigen
Find 3 more new buyers
Similar Companies to Navigen
Analyze insights from companies similar to Navigen and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Salituro Medchem Solutions<25
<$5M - Blossomhill Therapeutics<25<$5M
- Provid Pharmaceuticals<25<$5M
- New Equilibrium Biosciences<25<$5M
- Design Pharmaceuticals<25<$5M
- CADDmium<25$5.3M
- Kemxtree<25<$5M
- Orphagen Pharmaceuticals<25<$5M
More similar companies
Navigen financials insights
Gather financial insights about Navigen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Navigen Employee Growth Rate
View Navigen’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Navigen Tech Stack
Most Recent Scoops
Mar 13 2021
Funding
May 3 2020
Funding
Navigen News & Media
Navigen Announces FDA Clearance of its IND Application to Initiate First-in-Human Studies for CPT31, a Novel, D-peptide HIV Entry Inhibitor
SALT LAKE CITY, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Navigen, Inc. announced today that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug application ("IND") for the initiation of a Phase I study in healthy volunteers to test the safety, tolerability, and pharmacokinetics of its D-Peptide HIV entry inhibitor, CPT31.
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Navigen
Navigen has built a world-class D-peptide discovery platform. It is leveraging the unique characteristics of D-peptides to develop what it believes will be novel and potentially best-in-class therapies. In addition to CPT31, Navigen has a pipeline of discovery programs targeting inflammatory conditions and cancer.... Read More
